ResMed’s Quarterly Results Out, Revenue Grows 10%

A world-leading digital health company ResMed Inc (ASX:RMD, NYSE:RMD) announced results for its quarter ended 30 September 2020. The highlights are-

  • Revenue rose by 10% to $751.9 million, up by 9% on a cc basis.
  • Net operating profit during the period increased by 27% and non-GAAP operating profit up 24%.
  • The Company stated revenue in the US, Canada, and Latin America increased by 9% (excluding Software as a Service).

This surge is driven by strong sales across the mask product portfolio and increased demand for ventilators of ResMed due to COVID-19.

On 30 October 2020, the shares of RMD were trading at A$27.94 up by 9.525% at AEDT 12:45 PM.






Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK